Variant report
Variant | nsv946437 |
---|---|
Chromosome Location | chr1:158164685-158166531 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr1:158165746-158165749 | MCF-7 | breast: | n/a | n/a |
2 | CTCF | chr1:158165761-158165779 | MCF-7 | breast: | n/a | n/a |
3 | MAFF | chr1:158164513-158164693 | HepG2 | liver: | n/a | chr1:158164578-158164596 |
4 | MAFK | chr1:158164496-158164721 | IMR90 | lung: | n/a | chr1:158164644-158164655 chr1:158164644-158164655 chr1:158164579-158164594 chr1:158164643-158164654 chr1:158164643-158164659 |
5 | MAFK | chr1:158164452-158164724 | HepG2 | liver: | n/a | chr1:158164644-158164655 chr1:158164644-158164655 chr1:158164579-158164594 chr1:158164643-158164654 chr1:158164643-158164659 |
6 | MYC | chr1:158165626-158165739 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | POLR2A | chr1:158166438-158166555 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | POLR2A | chr1:158165575-158165717 | MCF-7 | breast: | n/a | n/a |
9 | POLR2A | chr1:158165729-158165736 | MCF-7 | breast: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CD1B-5 | chr1:158165423-158165921 | NONHSAT006974 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000229914 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs143653025 | chr1:158164685-158164686 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs1627504 | chr1:158164697-158164698 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs572896115 | chr1:158164755-158164756 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs374610975 | chr1:158164787-158164788 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs1628340 | chr1:158164788-158164789 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs577045516 | chr1:158164799-158164800 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs1628370 | chr1:158164800-158164801 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs562343128 | chr1:158164801-158164802 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188730181 | chr1:158164831-158164832 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs200952802 | chr1:158164841-158164842 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs193285842 | chr1:158164872-158164873 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs61820260 | chr1:158164919-158164920 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561179716 | chr1:158164934-158164935 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528607995 | chr1:158164941-158164942 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546642971 | chr1:158164952-158164953 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565307721 | chr1:158164962-158164963 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548977594 | chr1:158164973-158164974 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs1630031 | chr1:158164992-158164993 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs1630058 | chr1:158165004-158165005 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs569579509 | chr1:158165039-158165040 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs536793444 | chr1:158165096-158165097 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs185647514 | chr1:158165139-158165140 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs566407348 | chr1:158165152-158165153 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533919396 | chr1:158165163-158165164 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs557809413 | chr1:158165178-158165179 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562742558 | chr1:158165179-158165180 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558248937 | chr1:158165189-158165190 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs36071349 | chr1:158165190-158165191 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs202139509 | chr1:158165191-158165192 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs200445314 | chr1:158165192-158165193 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576821937 | chr1:158165199-158165200 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs528057268 | chr1:158165336-158165337 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs1690775 | chr1:158165341-158165342 | Weak transcription Strong transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs66697811 | chr1:158165357-158165358 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs199663672 | chr1:158165366-158165367 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75037519 | chr1:158165367-158165368 | Weak transcription Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs201729004 | chr1:158165415-158165416 | Weak transcription Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs553949210 | chr1:158165425-158165426 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs547797184 | chr1:158165486-158165487 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs540767610 | chr1:158165531-158165532 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs565124874 | chr1:158165569-158165570 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs1633127 | chr1:158165578-158165579 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs544620130 | chr1:158165591-158165592 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs1633128 | chr1:158165601-158165602 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs372712221 | chr1:158165624-158165625 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs188159771 | chr1:158165639-158165640 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs382436 | chr1:158165661-158165662 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs559782123 | chr1:158165669-158165670 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs369931485 | chr1:158165683-158165684 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs567080543 | chr1:158165688-158165689 | Weak transcription Enhancers Strong transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Glomerulonephritis | 19341492 | CNVD |
Systemic lupus erythematosus | 18559452 | CNVD |
Systemic autoimmune disease | 17597778 | CNVD |
Glomerulonephritis | 17008540 | CNVD |
Glomerulonephritis | 16482158 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Breast cancer | 21045282 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:158159800-158165400 | Weak transcription | Thymus | Thymus |
2 | chr1:158161600-158165800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
3 | chr1:158161600-158167000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr1:158161600-158167200 | Weak transcription | H9 Cell Line | embryonic stem cell |
5 | chr1:158163600-158165200 | Weak transcription | H1 Cell Line | embryonic stem cell |
6 | chr1:158163800-158166600 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
7 | chr1:158163800-158166800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
8 | chr1:158164000-158166600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
9 | chr1:158164000-158172800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr1:158164400-158167200 | Strong transcription | Dnd41 | blood |
11 | chr1:158165400-158165600 | Enhancers | H1 Cell Line | embryonic stem cell |
12 | chr1:158165400-158166000 | Enhancers | Pancreas | Pancrea |
13 | chr1:158165400-158166000 | Strong transcription | Thymus | Thymus |
14 | chr1:158165600-158167200 | Weak transcription | Fetal Thymus | thymus |
15 | chr1:158165800-158166000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
16 | chr1:158166000-158168600 | Weak transcription | Thymus | Thymus |
17 | chr1:158166000-158169800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
18 | chr1:158166400-158166600 | Enhancers | Duodenum Mucosa | Duodenum |